Gilead Sciences
In Brief This Week: Ultima Genomics, Scale Bio, Mainz Biomed, Eurofins, Synlab, GenomeDE, More
News items for the week of March 31, 2025.
Researchers Showcase New Scores, Biomarkers, Signatures for Predicting CAR T-Cell Outcomes at ASH
Premium
Across three studies, researchers demonstrated how various biomarkers can inform trial design and predict lymphoma patients' outcomes on CAR T-cell therapy.
DiaSorin Q3 Non-COVID-19 Revenues Rise 2 Percent, Collaborates With Gilead Sciences on HDV Assay
The firm reported its immunodiagnostics revenues rose on strong sales in Europe and North America while molecular instrument sales normalized from previous highs.
Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery
Second Genome will use its Microbiome Analytics platform to identify novel biomarkers linked to clinical responses to Gilead's investigational medicines.
The international firm is one of several pharmaceutical companies emphasizing new single-cell technologies to improve existing drugs and find new ones.
Oct 23, 2014
Yale, Gilead Extend Cancer Collaboration
Dec 23, 2011
Jan 7, 2011